{"symbol":"ABT","fiscalQuarter":"Q2-2018","reportDate":"2018-07-18","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q2-2018","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Up 3.11%","keyNumbers":[{"metric":"EPS","actual":"$0.73","expected":"N/A","surprise":"+0.78%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Abbott Laboratories reported a positive surprise on EPS, which contributed to a 3.11% increase in its stock price. However, without revenue figures or management commentary, it's difficult to assess the overall performance and future outlook. Investors may be encouraged by the earnings beat, but the lack of additional context leaves some uncertainty.","metaDescription":"Abbott Laboratories (ABT) Q2 2018 earnings: EPS beat by 0.78%. Stock up 3.11%. Full breakdown."}}